3644 results for «2748»
3644 results
Factors to consider during lifetime planning for TAVI patients
19 Feb 2023 – From PCR Tokyo Valves 2023
In this session, explore factors influencing lifetime prognosis and complication avoidance strategies in TAVI patients, focusing on pacemaker and paravalvular leak risk factors.
Left main - DK crush stenting: LIVE case from National University Heart Centre - Singapore
06 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 1
06 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 1
06 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 3
06 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 2
06 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 2
06 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 3
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Structural interventions - Session 6
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 5
07 Oct 2022 – From AICT-AsiaPCR 2022
TAVI
18 Feb 2023 – From PCR Tokyo Valves 2023
Discover a selection of cases exploring TAVI at PCR Tokyo Valves 2023 in this session: long-term survival assessment after TAVI, cerebral embolic protection devices for stroke prevention, ultrasound-guided vs. conventional MANTA vascular closure devices, and more!
Tricuspid valve interventions - Case studies
19 Nov 2023 – From PCR London Valves 2023
Explore a diverse range of tricuspid valve interventions through various case studies such as the multimodality percutaneous treatment of severe tricuspid regurgitation, Triclip subacute single leaflet detachment, bicaval valve implantation and more.
TAVI in complex scenarios
19 Nov 2023 – From PCR London Valves 2023
What do we mean by "complex scenarios"? When zero-contrast TAVI implantation becomes a good alternative in kidney disease, when TAVI is implanted in a patient with mechanical mitral valve, or when TAVI is implanted in very large annulus with subannular aneurysm, for example!
Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...
19 Nov 2023 – From PCR London Valves 2023
Discover the mitral late-breaking trials which were presented during PCR London Valves 2023:
- One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
- AltaValve transseptal programme update
- Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
- Combined impact of mitral valve gradients and mitral regurgitation reduction...
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices
20 Nov 2023 – From PCR London Valves 2023
Find out the outcomes of the main studies on the latest-generation valves and devices presented at PCR LV 2023 to better determine their benefits, performance and interest in the treatment of specific aortic pathologies: REACCESS-2 Study, ACURATE Neo2 PMCF post-market registry, OCEAN-TAVI registry, ShortCut Pivotal Study, and...
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
TAVI outcomes - Part 1
19 Nov 2023 – From PCR London Valves 2023
Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...
Tricuspid TEER - Part 2
20 Nov 2023 – From PCR London Valves 2023
